Some patients with locally advanced esophageal cancer may be able to safely forgo esophagectomy after CRT, data suggest.
Oral semaglutide, already approved for type 2 diabetes, led to a reduction in CV events in patients with established ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback